Impact of the COVID-19 Pandemic on the Delivery of Dermatological Care

por Kimball, Alexa B., Porter, Martina L.
Publicado 2022

Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infant

por Gibson, Ruby S., Porter, Martina L., Kimball, Alexa B.
Publicado 2021

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa

por Gibson, Ruby S., Porter, Martina L., Kimball, Alexa B.
Publicado 2022

32688 Evaluation of demographics for patients on immunomodulatory therapy during the COVID-19 pandemic

por Gibson, Ruby S., Santillan, Monica Rosales, Porter, Martina L.
Publicado 2022

33892 Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic

por Kim, Diana S., Kimball, Alexa B., Porter, Martina L.
Publicado 2022

Obstacles to Early Diagnosis and Treatment of Hidradenitis Suppurativa: Current Perspectives on Improving Clinical Management

por Snyder, Corey L, Chen, Stella X, Porter, Martina L
Publicado 2023

Update on biologic safety for patients with psoriasis during pregnancy

por Porter, Martina L., Lockwood, Stephen J., Kimball, Alexa B.
Publicado 2017

Response to: Remission of hidradenitis suppurativa after bariatric surgery

por Golbari, Nicole Mona, Lee Porter, Martina, Kimball, Alexa Boer
Publicado 2018

Sunscreen recommendations for patients with skin of color in the popular press and in the dermatology clinic

por Song, Hannah, Beckles, Ashley, Salian, Prerna, Porter, Martina L.
Publicado 2020

TNF-α inhibitors in the treatment of hidradenitis suppurativa

por Savage, Kevin T., Flood, Kelsey S., Porter, Martina L., Kimball, Alexa B.
Publicado 2019

COVID-19 impacts on dermatologic surgery patients: A single institution experience

por Danesh, Melissa J., Porter, Martina, Brag, Katherine, Salian, Prerna, Olbricht, Suzanne
Publicado 2021

Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study

por Kim, Diana S., Giannotti, Nicole, Salian, Prerna, Kimball, Alexa B., Porter, Martina L.
Publicado 2022

Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients

por Savage, Kevin T., Santillan, Monica Rosales, Flood, Kelsey S., Charrow, Alexandra, Porter, Martina L., Kimball, Alexa B.
Publicado 2020

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa

por Savage, Kevin T., Brant, Elena Gonzalez, Rosales Santillan, Monica, Morss, Peyton C., Salian, Prerna, Flood, Kelsey S., Porter, Martina L., Kimball, Alexa B.
Publicado 2020

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities

por Morss-Walton, Peyton C., Greif, Charlotte, Holcomb, Zachary E., Salian, Prerna, Yankama, Tuyen, Kim, Diana, Porter, Martina L., Kimball, Alexa B.
Publicado 2022

Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy

por Holcomb, Zachary E., Santillan, Monica Rosales, Morss-Walton, Peyton C., Salian, Prerna, Her, Min Ji, Giannotti, Nicole M., Kimball, Alexa B., Porter, Martina L.
Publicado 2020

Provider perspectives on the management of hidradenitis suppurativa in pregnancy – A survey study

por Collier, Erin K., Price, Kyla N., Grogan, Tristan, Fernandez, Jennifer M., Seivright, Justine R., Alhusayen, Raed, Alavi, Afsaneh, Hamzavi, Iltefat H., Lowes, Michelle A., Porter, Martina J., Shi, Vivian Y., Hsiao, Jennifer L.
Publicado 2020